HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Luca Richeldi Selected Research
Luca Richeldi Research Topics
Disease
78
Idiopathic Pulmonary Fibrosis
05/2024 - 09/2010
23
Disease Progression
01/2023 - 09/2010
21
Fibrosis (Cirrhosis)
09/2023 - 09/2011
14
Tuberculosis (Tuberculoses)
12/2019 - 05/2004
13
Interstitial Lung Diseases (Interstitial Lung Disease)
03/2022 - 04/2014
11
Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2024 - 01/2002
11
Infections
01/2024 - 05/2004
8
COVID-19
01/2024 - 01/2020
8
Lung Diseases (Lung Disease)
01/2022 - 10/2011
6
Pneumonia (Pneumonitis)
10/2023 - 07/2012
5
Sarcoidosis (Schaumann Disease)
01/2022 - 01/2005
4
Chronic Obstructive Pulmonary Disease (COPD)
01/2024 - 01/2010
4
Neoplasms (Cancer)
01/2021 - 01/2013
3
Dyspnea (Shortness of Breath)
04/2022 - 11/2018
3
Inflammation (Inflammations)
01/2022 - 01/2020
3
Hypoxia (Hypoxemia)
01/2022 - 01/2020
3
Asthma (Bronchial Asthma)
10/2021 - 10/2020
3
Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
12/2019 - 01/2007
3
Diarrhea
10/2019 - 05/2014
3
Bronchiectasis
06/2018 - 01/2017
3
Connective Tissue Diseases (Connective Tissue Disease)
02/2018 - 02/2013
3
Latent Tuberculosis
07/2010 - 04/2006
2
Granuloma
01/2022 - 01/2005
2
Respiratory Tract Diseases (Respiratory Tract Disease)
01/2021 - 07/2012
2
Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
04/2020 - 01/2020
2
Idiopathic Interstitial Pneumonias
01/2020 - 12/2005
2
Respiratory Tract Infections (Respiratory Tract Infection)
01/2020 - 07/2012
2
Respiratory Sounds (Crackle)
06/2018 - 03/2014
2
Lymphangioleiomyomatosis (Lymphangiomyomatosis)
01/2014 - 10/2011
2
Latent Infection
06/2011 - 01/2007
2
Pulmonary Tuberculosis
10/2009 - 05/2004
1
Type IV Ehlers-Danlos Syndrome
05/2024
1
Airway Obstruction (Choking)
01/2023
1
Rare Diseases (Rare Disease)
12/2022
1
Cicatrix (Scar)
12/2022
1
Cough
01/2022
1
Critical Illness (Critically Ill)
12/2021
1
Human Influenza (Influenza)
12/2021
1
Fever of Unknown Origin
11/2021
1
Allergic Rhinitis
10/2021
Drug/Important Bio-Agent (IBA)
50
nintedanib
IBA
05/2024 - 09/2011
24
pirfenidone
IBA
05/2024 - 09/2010
10
Biomarkers (Surrogate Marker)
IBA
11/2021 - 11/2009
10
Tuberculin (PPD)
IBA
07/2010 - 05/2004
7
Gold
IBA
01/2021 - 09/2005
5
Monoclonal Antibodies
IBA
05/2024 - 01/2020
5
Steroids
IBA
01/2023 - 12/2005
5
BI 1015550
IBA
01/2023 - 01/2022
5
Enzymes
IBA
11/2021 - 08/2004
5
Carbon Monoxide
IBA
01/2020 - 09/2013
4
pamrevlumab
IBA
05/2024 - 01/2020
4
Collagen
IBA
01/2022 - 10/2012
4
Antigens
IBA
04/2020 - 01/2005
4
Anti-Bacterial Agents (Antibiotics)
IBA
01/2017 - 01/2009
4
Interferon-gamma (Interferon, gamma)
IBA
07/2010 - 06/2005
3
Formoterol Fumarate (Oxis)
FDA Link
01/2024 - 01/2021
3
Oxygen (Dioxygen)
IBA
12/2022 - 01/2021
3
Azathioprine (Imuran)
FDA Link
Generic
01/2022 - 05/2004
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2021 - 06/2012
3
Autoantibodies
IBA
10/2015 - 01/2013
3
Interferons
IBA
06/2011 - 09/2005
2
Connective Tissue Growth Factor
IBA
05/2024 - 01/2020
2
Beclomethasone (Beclometasone)
FDA Link
01/2024 - 01/2021
2
Glycopyrrolate (Glycopyrronium Bromide)
FDA Link
Generic
01/2024 - 01/2021
2
COVID-19 Vaccines
IBA
01/2024 - 01/2022
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2023 - 01/2013
2
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
01/2023 - 01/2022
2
C-Reactive Protein
IBA
04/2022 - 10/2021
2
Antifibrotic Agents
IBA
01/2022 - 09/2021
2
Cytokines
IBA
01/2022 - 07/2010
2
Phosphotransferases (Kinase)
IBA
01/2022 - 10/2019
2
Immune Checkpoint Inhibitors
IBA
01/2021 - 01/2021
2
Glycoproteins (Glycoprotein)
IBA
01/2020 - 10/2014
2
Proteins (Proteins, Gene)
FDA Link
01/2019 - 01/2014
2
beta-cyclodextrin tetradecasulfate (CTDS)
IBA
05/2014 - 04/2014
2
lipoarabinomannan (LAM)
IBA
01/2014 - 10/2011
1
Collagen Type III (Type III Collagen)
IBA
05/2024
1
Vaccines
IBA
01/2024
1
P-Selectin
IBA
09/2023
1
tocilizumab (atlizumab)
FDA Link
01/2023
1
Protein Isoforms (Isoforms)
IBA
01/2023
1
Rituximab (Mabthera)
FDA Link
01/2023
1
fibrin fragment D (D-dimer)
IBA
04/2022
1
Nitrogen
IBA
04/2022
1
Urea (Carbamide)
FDA Link
Generic
04/2022
1
Phosphodiesterase 4 Inhibitors
IBA
01/2022
1
Cromolyn Sodium (Cromoglicic Acid)
FDA Link
Generic
01/2022
1
CC-90001
IBA
01/2022
1
Protein Kinases (Protein Kinase)
IBA
01/2022
1
JNK Mitogen-Activated Protein Kinases
IBA
01/2022
1
chitotriosidase
IBA
11/2021
1
Sodium
IBA
10/2021
Therapy/Procedure
36
Therapeutics
02/2024 - 05/2004
3
Lung Transplantation
01/2023 - 12/2018
3
Drug Therapy (Chemotherapy)
03/2022 - 01/2013
3
Traction
06/2018 - 01/2017
2
Precision Medicine
02/2024 - 01/2016
2
Nebulizers and Vaporizers (Inhaler)
01/2024 - 01/2021
2
Critical Care (Surgical Intensive Care)
12/2021 - 01/2020
1
Palliative Care (Palliative Therapy)
01/2023